Selected article for: "current study and potential risk"
Author: Kenichiro Sato; Tatsuo Mano; Atsushi Iwata; Tatsushi Toda
Title: Neuropsychiatric adverse events of chloroquine: A real-world pharmacovigilance study using the FAERS database
  • Document date: 2020_4_14
    • ID: buzj06i6_31
    Snippet: To conclude, the current pharmacovigilance study, using the FAERS database, did not suggest a potential link between the use of chloroquine and an increased risk of suicide or psychosis. These results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with COVID-19. Since this study was based on a self-reporting database that inevitably contains several biases, cohort studies are need.....
    Document: To conclude, the current pharmacovigilance study, using the FAERS database, did not suggest a potential link between the use of chloroquine and an increased risk of suicide or psychosis. These results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with COVID-19. Since this study was based on a self-reporting database that inevitably contains several biases, cohort studies are needed, to validate these results and to confirm the neuropsychiatric safety of chloroquine.

    Search related documents:
    Co phrase search for related documents
    • cohort study and patient treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cohort study and potential link: 1
    • cohort study and psychosis suicide: 1, 2
    • cohort study and psychosis suicide increase risk: 1, 2
    • current pharmacovigilance study and FAERS database: 1, 2
    • current pharmacovigilance study and pharmacovigilance study: 1, 2, 3
    • current pharmacovigilance study and potential link: 1, 2
    • current pharmacovigilance study and psychosis suicide: 1, 2
    • FAERS database and pharmacovigilance study: 1, 2, 3, 4
    • FAERS database and potential link: 1, 2
    • FAERS database and psychosis suicide: 1, 2
    • increase risk and patient treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • increase risk and potential link: 1, 2
    • increase risk and psychosis suicide: 1, 2
    • increase risk and psychosis suicide increase risk: 1, 2
    • neuropsychiatric safety and patient treatment: 1
    • pharmacovigilance study and potential link: 1, 2
    • pharmacovigilance study and psychosis suicide: 1, 2